PINK COPYRIGHT: A GROWING DANGER?

A concerning development is surfacing within the substance scene: "Pink copyright," formally known as Flunitramadol. This synthetic opioid is being marketed as a crystal , often presented as copyright, posing a serious threat to users . Its seemingly low cost and simple accessibility are fueling